Literature DB >> 21482089

The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease.

Gloria Soldevila1, Chander Raman, Francisco Lozano.   

Abstract

CD5 is a scavenger-like receptor expressed in association with the antigen-specific receptors on T and B-1a lymphocytes. Recent studies reveal a broader biology for CD5 that includes its role as regulator of cell death and as a receptor for pathogen-associated molecular patterns, in addition to its previously described function as an inhibitory receptor. These findings shed new light into the mechanistic role of CD5 in leukemias and effector cells to exogenous (infectious) or endogenous (autoimmune, tumoral) antigens. The newly identified properties make this receptor a potential candidate to be targeted for therapeutic intervention as well as immune modulation. This review describes the current knowledge on the function of CD5 as an immunomodulatory receptor both in health and in disease.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21482089      PMCID: PMC3109098          DOI: 10.1016/j.coi.2011.03.003

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  56 in total

1.  Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis.

Authors:  Flavia De Bernardis; Roberta Lucciarini; Maria Boccanera; Consuelo Amantini; Silvia Arancia; Stefania Morrone; Michela Mosca; Antonio Cassone; Giorgio Santoni
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Natural phosphorylation of CD5 in chronic lymphocytic leukemia B cells and analysis of CD5-regulated genes in a B cell line suggest a role for CD5 in malignant phenotype.

Authors:  Hélène Gary-Gouy; Alexander Sainz-Perez; Jean-Brice Marteau; Anne Marfaing-Koka; Jozo Delic; Hélène Merle-Beral; Pierre Galanaud; Ali Dalloul
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

Review 3.  B-1 B cells: development, selection, natural autoantibody and leukemia.

Authors:  Richard R Hardy
Journal:  Curr Opin Immunol       Date:  2006-08-01       Impact factor: 7.486

4.  CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system.

Authors:  Robert C Axtell; Liang Xu; Scott R Barnum; Chander Raman
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

5.  Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells.

Authors:  Natasha K Crellin; Rosa V Garcia; Omeed Hadisfar; Sarah E Allan; Theodore S Steiner; Megan K Levings
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

6.  Toll-like receptor 2 controls expansion and function of regulatory T cells.

Authors:  Roger P M Sutmuller; Martijn H M G M den Brok; Matthijs Kramer; Erik J Bennink; Liza W J Toonen; Bart-Jan Kullberg; Leo A Joosten; Shizuo Akira; Mihai G Netea; Gosse J Adema
Journal:  J Clin Invest       Date:  2006-01-19       Impact factor: 14.808

7.  Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function.

Authors:  Guangyong Peng; Zhong Guo; Yukiko Kiniwa; Kui Shin Voo; Weiyi Peng; Tihui Fu; Daniel Y Wang; Yanchun Li; Helen Y Wang; Rong-Fu Wang
Journal:  Science       Date:  2005-08-26       Impact factor: 47.728

8.  Autoreactive B-1 B cells: constraints on natural autoantibody B cell antigen receptors.

Authors:  Ben Rowley; Lingjuan Tang; Susan Shinton; Kyoko Hayakawa; Richard R Hardy
Journal:  J Autoimmun       Date:  2007-09-21       Impact factor: 7.094

9.  Human CD5 protects circulating tumor antigen-specific CTL from tumor-mediated activation-induced cell death.

Authors:  Grzegorz Friedlein; Faten El Hage; Isabelle Vergnon; Catherine Richon; Patrick Saulnier; Yann Lécluse; Anne Caignard; Laurence Boumsell; Georges Bismuth; Salem Chouaib; Fathia Mami-Chouaib
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

10.  CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shock.

Authors:  Maria-Rosa Sarrias; Montserrat Farnós; Rubén Mota; Fernando Sánchez-Barbero; Anna Ibáñez; Idoia Gimferrer; Jorge Vera; Rafael Fenutría; Cristina Casals; José Yélamos; Francisco Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-29       Impact factor: 11.205

View more
  41 in total

1.  Pulsed high-dose dexamethasone improves interleukin 10 secretion by CD5+ B cells in patients with primary immune thrombocytopenia.

Authors:  Fanli Hua; Lili Ji; Yanxia Zhan; Feng Li; Shanhua Zou; Xiaoyun Wang; Dongli Song; Zhihui Min; Song Gao; Yangjiong Wu; Hao Chen; Yunfeng Cheng
Journal:  J Clin Immunol       Date:  2012-06-06       Impact factor: 8.317

2.  Transitional B cell subsets in human bone marrow.

Authors:  S Agrawal; S A B C Smith; S G Tangye; W A Sewell
Journal:  Clin Exp Immunol       Date:  2013-10       Impact factor: 4.330

3.  Clinical outcomes in chronic lymphocytic leukaemia associated with expression of CD5, a negative regulator of B-cell receptor signalling.

Authors:  Daphne R Friedman; Eross Guadalupe; Alicia Volkheimer; Joseph O Moore; J Brice Weinberg
Journal:  Br J Haematol       Date:  2018-11-08       Impact factor: 6.998

4.  HIV, Cytomegalovirus, and Malaria Infections during Pregnancy Lead to Inflammation and Shifts in Memory B Cell Subsets in Kenyan Neonates.

Authors:  Kee Thai Yeo; Paula Embury; Timothy Anderson; Peter Mungai; Indu Malhotra; Christopher King; James Kazura; Arlene Dent
Journal:  J Immunol       Date:  2019-01-23       Impact factor: 5.422

5.  CD5+ diffuse large B-cell lymphoma with hemophagocytosis.

Authors:  Jan K Davidson-Moncada; Emily McDuffee; Mark Roschewski
Journal:  J Clin Oncol       Date:  2012-11-26       Impact factor: 44.544

6.  CD5 enhances Th17-cell differentiation by regulating IFN-γ response and RORγt localization.

Authors:  Donald J McGuire; Amber L Rowse; Hao Li; Binghao J Peng; Christine M Sestero; Kevin S Cashman; Patrizia De Sarno; Chander Raman
Journal:  Eur J Immunol       Date:  2014-01-16       Impact factor: 5.532

7.  Immunomodulatory Functions of BTLA and HVEM Govern Induction of Extrathymic Regulatory T Cells and Tolerance by Dendritic Cells.

Authors:  Andrew Jones; Jessica Bourque; Lindsey Kuehm; Adeleye Opejin; Ryan M Teague; Cindy Gross; Daniel Hawiger
Journal:  Immunity       Date:  2016-10-25       Impact factor: 31.745

Review 8.  B cell-mediated pathogenesis of ANCA-mediated vasculitis.

Authors:  J Charles Jennette; Ronald J Falk
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

9.  Altered B Cell Homeostasis in Patients with Major Depressive Disorder and Normalization of CD5 Surface Expression on Regulatory B Cells in Treatment Responders.

Authors:  Diana Ahmetspahic; Kathrin Schwarte; Oliver Ambrée; Christian Bürger; Vladislava Falcone; Katharina Seiler; Mehrdad Rahbar Kooybaran; Laura Grosse; Fernand Roos; Julia Scheffer; Silke Jörgens; Katja Koelkebeck; Udo Dannlowski; Volker Arolt; Stefanie Scheu; Judith Alferink
Journal:  J Neuroimmune Pharmacol       Date:  2017-09-13       Impact factor: 4.147

10.  CD5-dependent CK2 activation pathway regulates threshold for T cell anergy.

Authors:  Christine M Sestero; Donald J McGuire; Patrizia De Sarno; Emily C Brantley; Gloria Soldevila; Robert C Axtell; Chander Raman
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.